Terms ending in 2036
Every in-force patent on Amgen Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,840,736 | Nucleic Acid Biomarker and Use Thereof In force · High confidence | Daiichi Sankyo Europe GmbH | In force | High confidence | |
| US 10,561,800 | Skin Sensors for Drug Delivery Devices In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,040,135 | Integrated Pierceable Seal Fluid Pathway Connection and Drug Containers for Drug Delivery Pumps In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,303,674 | Drug Injection Device with Visual and Audio Indicators In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 10,611,850 | Crystalline Antibody Formulations In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,773,184 | Crystalline Antibody Formulations In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,873,344 | Protein Biomarker and Uses Thereof In force · High confidence | Daiichi Sankyo Europe GmbH | In force | High confidence | |
| US 10,933,132 | Combination of Epigenetic Factors and Bispecific Compounds Targeting CD33 and CD3 in the Treatment of Myeloid Leukemia In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,672,905 | Rotationally Biased Insertion Mechanism for a Drug Delivery Pump In force · Medium confidence | Amgen Inc. | In force | Medium confidence | |
| US 12,208,237 | Rotationally Biased Insertion Mechanism for a Drug Delivery Pump In force · High confidence | Amgen Inc. | In force | High confidence | |
| 58 more term ends in 2036 · Pro | |||||
10 of 68 patents shown. Soonest term end first, then patent number.
Pro members see all 68.
63 of these are in force and held by Amgen Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.